Related by context. All words. (Click for frequent words.) 78 myocardial infarction stroke 77 nonfatal MI 77 nonfatal myocardial infarction 75 nonfatal stroke 75 reinfarction 72 cardiovascular hospitalization 72 recurrent ischemia 72 nonfatal myocardial infarction MI 72 cardiovascular hospitalizations 70 fatal myocardial infarction 69 cerebrovascular events 69 Erythropoietic therapies may 69 ipsilateral stroke 68 CHD CVD 68 resuscitated cardiac arrest 68 CVD mortality 68 myocardial infarction MI 67 macrovascular events 67 LVSD 67 symptomatic VTE 67 LV dysfunction 67 periprocedural 67 Myocardial infarction 67 recurrent myocardial infarction 66 composite endpoint 66 arterial thromboembolic events 66 postoperative AF 66 thromboembolism 66 noncardiac 66 stroke myocardial infarction 66 de ath 65 recurrent venous thromboembolism 65 % CI #.#-#.# [007] 65 repeat revascularization 65 rebleeding 65 thrombotic events 65 % CI #.#-#.# [006] 65 atherothrombotic disease 65 recurrent DVT 64 ischemia driven 64 refractory ischemia 64 unstable angina pectoris 64 renal insufficiency 64 coronary revascularization 64 inhospital 64 cardiovascular mortality 64 noncardiovascular mortality 64 VT VF 64 cardiac dysfunction 64 MACCE 64 intracerebral haemorrhage 64 thromboembolic 64 % CI #.#-#.# [008] 64 TEAEs 63 perioperative complications 63 nonfatal pulmonary embolism 63 TAXUS p value 63 severe exacerbations 63 decompensated heart failure 63 confidence interval #.#-#.# 63 atherothrombotic 63 carotid stenosis 63 atrioventricular block 63 ATACAND 63 binary restenosis 63 silent ischemia 63 NSTEMI 63 hypoxemia 63 morbidity mortality 63 postoperative complication 63 multivariate adjustment 63 Stent thrombosis 63 nondiabetic patients 63 hemorrhagic complications 63 upper gastrointestinal bleeding 63 dysrhythmias 63 β blockers 63 CI #.#-#.# [002] 63 fatal pulmonary embolism 62 Postoperative complications 62 myocardial infarction 62 perioperative mortality 62 salmeterol HFA MDI 62 cerebrovascular accidents 62 ventricular fibrillation VF 62 hepatorenal syndrome 62 rehospitalization 62 Hypotension 62 thromboembolic complications 62 Renal dysfunction 62 nontraumatic 62 SCr 62 Secondary endpoints included 62 preserved ejection fraction 62 fatal IHD 62 proximal DVT 62 noncardiovascular 62 thromboembolic events 62 definite stent thrombosis 62 syncopal 62 tumor lysis syndrome 62 liver decompensation 62 histologic subtype 62 events MACE 62 intima media thickness 62 venous thromboembolic disease 62 elevated IOP 62 renal dysfunction 62 preoperative PSA 62 ischemic complications 62 morphometric vertebral fractures 62 ischemic cardiomyopathy 62 Secondary endpoints include 62 postintervention 62 hyperglycaemia 62 hepatic failure 61 revascularizations 61 p = NS 61 adverse perinatal 61 perinatal morbidity 61 hypertension diabetes mellitus 61 neonatal morbidity 61 cerebrovascular accident 61 pCR 61 arterial revascularization hospitalization 61 cytopenias 61 HIV HCV coinfected 61 ventricular dysfunction 61 ischemic cardiovascular 61 neurologic complications 61 Primary endpoints 61 CI #.#-#.# [001] 61 acute myocardial infarction AMI 61 hypoglycemic events 61 myocardial infarctions 61 symptomatic intracranial 61 extrapyramidal symptoms 61 pericardial effusion 61 autonomic dysfunction 61 myocardial fibrosis 61 recurrent VTE 61 XIENCE V PROMUS Stent 61 torsade de pointes 61 coagulopathy 61 deep venous thromboses 61 beta blocker therapy 61 NYHA Class II 61 circulatory diseases 61 bronchopulmonary dysplasia 61 target vessel revascularization 61 nonadherence 61 % CI #.#-#.# [004] 61 hyperkalemia 61 generalized edema 61 confidence interval CI 61 pulmonary embolism PE 61 glycated hemoglobin levels 61 nonfatal cardiovascular 61 thrombocytopenic 61 postoperative mortality 61 serum parathyroid hormone 61 ischemic cerebrovascular 61 pulmonary capillary wedge 61 torsades de pointes 61 postoperative morbidity 61 renal scarring 61 thrombocytosis 61 alanine aminotransferase 61 colorectal adenoma 60 unknown etiology 60 malignant neoplasm 60 coronary revascularization procedures 60 posttransplant 60 PSA nadir 60 undergoing coronary artery 60 nonischemic 60 acute coronary 60 IPAH 60 sustained ventricular tachycardia 60 p = .# [002] 60 neurologic sequelae 60 dermatologic reactions 60 valvular heart disease 60 Events MACE 60 distant metastasis 60 troponin T 60 nodal metastases 60 apnea hypopnea 60 psychiatric comorbidities 60 QTc prolongation 60 NIHSS score 60 myocardial infarction ventricular fibrillation 60 ketoacidosis hyperosmolar coma 60 valvular disease 60 cardiopulmonary diseases 60 intracranial hemorrhage ICH 60 hyperhomocysteinemia 60 carotid intima media 60 clinicopathological features 60 neutropenia dehydration dyspnea 60 cerebral infarction 60 HbA 1c levels 60 cerebral vascular disease 60 elevated ALT 60 cerebrovascular disease 60 systolic dysfunction 60 prolonged QT interval 60 p = #.# [003] 60 decompensation 60 pretransplant 60 pyrexia mucositis sepsis febrile 60 secondary efficacy endpoint 60 perioperatively 60 HBeAg 60 revascularisation 60 POAG 60 predisposing factor 60 myocardial ischemia 60 systemic embolism 60 embolic stroke 60 intraventricular hemorrhage 60 nonfasting triglyceride levels 60 diastolic blood pressures 60 Operative mortality 60 microvascular complications 60 acute myocardial infarctions 60 P = .# 60 lowest tertile 60 thromboses 60 #.#/#.# mmHg [001] 60 non valvular atrial 60 thyrotoxicosis 60 left ventricular dysfunction 60 intraoperative complications 60 ventricular tachycardia VT 60 artery stenosis 60 asymptomatic PAD 60 atherothrombosis 60 fetal malformations 60 variceal hemorrhage 60 response pCR 60 nadolol 60 thrombotic complications 60 thyrotropin levels 60 SSc 59 MI myocardial infarction 59 HOMA IR 59 hip BMD 59 severe hypoglycemic 59 acute coronary syndromes ACS 59 % CI #.#-#.# [001] 59 coma convulsions 59 leucopenia 59 myocardial infraction 59 serum aminotransferase levels 59 postdischarge 59 % Confidence Interval 59 MMSE score 59 mL/min/#.# m 2 59 periprocedural MI 59 advanced adenoma 59 carotid IMT 59 atherosclerotic cardiovascular disease 59 comorbid conditions 59 multivariable analysis 59 hyperacute 59 hypercalcaemia 59 elevated LDH 59 graft dysfunction 59 mitral stenosis 59 QTc intervals 59 cerebral oxygenation 59 tricuspid regurgitation 59 undergoing CABG 59 HbA1C levels 59 fluid overload 59 sinus node dysfunction 59 invasive aspergillosis 59 arterial revascularization 59 Diabetic nephropathy 59 severe neutropenia 59 cardiac tamponade 59 TMP SMX 59 stroke transient ischemic 59 pericardial effusions 59 aspartate aminotransferase AST 59 heparin induced thrombocytopenia 59 CTEPH 59 polyp recurrence 59 variant angina 59 highest tertile 59 induce orthostatic hypotension 59 x ULN 59 HBeAg seroconversion 59 pulmonary dysfunction 59 adnexal mass 59 confirmed thrombotic cardiovascular 59 ACEI ARB 59 hypertension congestive heart 59 unresectable HCC 59 MADRS score 59 acute aortic dissection 59 cerebral vasospasm 59 Proteinuria 59 Exacerbations 59 pulmonary exacerbations 59 acutely decompensated congestive heart 59 coinfected patients 59 glycosylated hemoglobin HbA1c 59 cardiovascular morbidity 59 TAXUS Express Stent 59 hepatic cirrhosis 59 biochemical recurrence 59 arterial thickening 59 urgent coronary revascularization 59 microbiologically evaluable 59 elevated transaminases 59 patients undergoing CABG 59 lymphocytosis 59 coronary stenosis 59 Severe hypoglycemia 59 echocardiographic parameters 59 CK MB 59 prospectively defined 59 EXJADE 59 arterial thromboembolic 59 pulmonary thromboembolism 59 untreated OSA 59 symptomatic atrial fibrillation 59 tachyarrhythmias 59 % CI #.#-#.# [005] 59 Infusion Reactions Severe 59 thrombophlebitis 59 XIENCE V demonstrated 59 infective endocarditis 59 preintervention 59 SLNB 59 histological subtype 59 microalbuminuria 59 Cardiogenic shock 59 nonsignificant 58 Tasigna prolongs 58 serum phosphorous 58 Orthostatic hypotension 58 XIENCE V vs. 58 multivariable adjusted 58 nasal polyposis 58 ventricular tachyarrhythmia 58 carotid artery blockage 58 % CI #.#-#.# [002] 58 hyperparathyroidism 58 platelet reactivity 58 NNT = 58 acute ischemic 58 NYHA functional class 58 CHD mortality 58 serum creatinine levels 58 supraventricular arrhythmias 58 serum estradiol 58 metabolic acidosis 58 neurodevelopmental impairment 58 comorbid anxiety 58 ARCOXIA 58 Pulmonary embolism 58 left ventricular systolic 58 Crohn Disease Activity 58 postoperative atrial fibrillation 58 receiving VELCADE 58 peri procedural 58 Thrombocytopenia 58 anemia neutropenia 58 Kaplan Meier estimates 58 neurologic dysfunction 58 asthma exacerbations 58 myocardial ischaemia 58 tumor regressions 58 cranial irradiation 58 β = 58 cerebro vascular 58 Unstable Angina 58 undergoing coronary angiography 58 dyslipidemia hypertension diabetes 58 hypovolemic shock 58 reoperations 58 tirofiban 58 estimated glomerular filtration 58 unfavorable cytogenetics 58 postoperative complications 58 malignant neoplasms 58 bronchial hyperresponsiveness 58 target lesion revascularization 58 atheroma volume 58 symptomatic pulmonary embolism 58 renal artery stenosis 58 Nesiritide 58 Major Adverse Cardiac 58 systolic hypertension 58 antithrombotic therapy 58 -#.# ± [002] 58 β blocker 58 aneurysmal subarachnoid hemorrhage 58 pg ml 58 cryptogenic stroke 58 comorbid psychiatric 58 hyperalgesia 58 bypass graft CABG surgery 58 cardiocirculatory 58 fractional shortening 58 paclitaxel eluting stents 58 congenital anomalies 58 stent thromboses 58 GH deficiency 58 spinal cord compression 58 multivariate Cox 58 parkinsonian symptoms 58 mmHg diastolic 58 corrected QT interval 58 hyperprolactinemia 58 debilitating complication 58 postpartum haemorrhage 58 multivariable analyzes 58 angiographic restenosis 58 atherosclerotic progression 58 psychiatric morbidity 58 neurocognitive deficits 58 transaminase elevations 58 microvascular disease 58 subclinical hypothyroidism 58 haematologic 58 hypoglycaemic episodes 58 variceal bleeding 58 interstitial pneumonitis 58 prostate cancer CaP 58 Venous thromboembolism 58 oxygen desaturation 58 abdominal adiposity 58 Low birthweight 58 fatal anaphylactic 58 coronary artery atherosclerosis 58 hepatic insufficiency 58 intravascular hemolysis 58 DES implantation 58 arterial oxygen saturation 58 SNHL 58 glycated hemoglobin HbA1c 58 nonfasting triglycerides 58 VTEs 58 hypophosphatemia 58 hypercalcemia 58 HRQoL 58 inhospital mortality 58 concomitant medications 58 SGRQ 58 coronary revascularisation 58 eplerenone 58 elevated triglyceride levels 58 pT3 58 nasopharyngitis headache 58 mild renal insufficiency 58 pretest probability 58 persistency mortality 58 Torsades de Pointes 58 arterial stenosis 58 Pulmonary hypertension 58 multisystem organ failure 58 acute cholecystitis 58 G6PD deficiency 58 cytopenia 58 dyspnoea 58 postoperative infections 58 nonvascular 58 elevated bilirubin 58 death reinfarction 58 asymptomatic carotid stenosis 58 acute decompensation 58 fibrinolysis 58 haemorrhagic strokes 58 headache abdominal pain 58 landmark ATHENA trial 57 fatal arrhythmic 57 Ischemic heart 57 liver histology 57 BMI z 57 onset atrial fibrillation 57 Febrile neutropenia 57 % CI #.#-#.# [003] 57 Mitral regurgitation 57 Uncontrolled hypertension 57 lipid lowering agents 57 Unstable angina 57 incidence ≥ 57 perinatal complications 57 graft occlusion 57 hypoglycemic episodes 57 ventricular remodeling 57 neutropaenia 57 hypercalciuria 57 venous thromboembolic events 57 everolimus eluting stents 57 Exclusion criteria 57 pacemaker implantation 57 dyssynchrony 57 cardiogenic shock 57 symptom exacerbation 57 Hip fracture 57 depressive symptomatology 57 left ventricular hypertrophy 57 intracerebral hemorrhage 57 salmeterol fluticasone 57 coagulation abnormalities 57 atherosclerotic coronary 57 neutropenia thrombocytopenia 57 pulmonary resection 57 myocardial infarction congestive heart 57 perinatal mortality 57 antithrombotic therapies 57 esophageal carcinoma 57 revascularization procedures 57 LVEF 57 Hazard Ratio 57 pulmonary toxicity 57 VcMP 57 Hb A1C 57 reintervention 57 intracranial haemorrhage 57 Coronary Artery Bypass Graft 57 chronic thromboembolic pulmonary 57 hemodynamic parameters 57 Endothelial dysfunction 57 testicular tumors 57 thromboprophylaxis 57 haematological toxicity 57 endometrial hyperplasia 57 FluCAM arm 57 ventricular repolarization 57 nonvertebral fracture 57 renal allograft 57 Arch Intern Med 57 antiphospholipid syndrome 57 thrombophilia 57 cytogenetic abnormalities 57 postprocedure 57 events TEAEs 57 dysfunction LVSD 57 familial AF 57 #q# deletion syndrome 57 hemodynamic instability 57 intrauterine fetal 57 hypomagnesemia 57 retransplantation 57 mcg kg REBETOL 57 myocardial infarctions MIs 57 nondiabetics 57 baseline HbA1c 57 ketoacidosis coma 57 parous women 57 Thrombotic thromboembolic complications 57 anastomotic leak 57 thromboembolic disease 57 mcg QD 57 affective psychoses 57 artery occlusion 57 confidence intervals CIs 57 laboratory abnormalities 57 chronic obstructive lung 57 ALT elevation 57 atopic sensitization 57 nmol liter 57 COPD exacerbation 57 receiving XGEVA 57 serum sodium levels 57 adrenal insufficiency 57 severe hypoglycaemia 57 gastric varices 57 somnolence sedation 57 HbA1c levels 57 HeFH 57 ventricular arrhythmia 57 lower extremity amputation 57 hypokalemia 57 progression TTP 57 macrovascular disease 57 gastrointestinal GI bleeding 57 VTE prophylaxis 57 peripartum 57 HBeAg negative patients 57 AST ALT 57 VTE 57 diastolic hypertension 57 somnolence dizziness 57 postoperative pulmonary 57 CCyR 57 abnormal lipid 57 olmesartan 57 fulminant 57 distensibility 57 elevated creatinine 57 attain statistical significance 57 serum triglycerides 57 electrolyte abnormalities 57 MIs 57 Secondary endpoints 57 gastrointestinal perforations 57 hippocampal atrophy 57 TT genotype 57 intact parathyroid hormone 57 Asymptomatic 57 neutrophil counts 57 Critical limb ischemia 57 atherogenic dyslipidemia 57 DAS# remission 57 Treatment emergent adverse 57 lactic acidosis 57 hemodynamically significant 57 % AST SGOT 57 angina myocardial infarction 57 acute myocardial infarction 57 univariate analysis 57 thrombocytopenia neutropenia 57 serum phosphate 57 rosuvastatin #mg 57 leukocyte count 57 del 5q MDS 57 idiopathic pulmonary arterial hypertension 57 symptomatic intracranial hemorrhage 57 hemodilution 57 diabetes mellitus hypertension 57 CI -#.# 57 spontaneous bacterial peritonitis 57 ventricular tachyarrhythmias 57 empyema 57 antiphospholipid antibodies 57 ST Segment Elevation 57 advanced neoplasia 57 Diastolic 57 carotid atherosclerosis 57 aneurysm ruptures 57 ictal 57 postoperative bleeding 57 ruptured aneurysms 57 arterial thrombotic 57 Prehypertension 57 cirrhosis liver failure 57 serum leptin 57 atherosclerotic CVD 57 natriuresis 57 syncope fainting 57 asthma exacerbation 57 nephrotoxicity 57 systemic hypotension 57 adenomatous polyps 57 ejection fractions 57 incomplete revascularization 57 Acetaminophen overdose 57 valvular 57 preterm neonates 57 dysmenorrhoea 57 bacteriuria 57 fulminant hepatitis 57 elevated lipase 57 Atherosclerotic 57 Hospitalizations 57 unfractionated heparin UFH 56 LV ejection fraction 56 severe asthma exacerbations 56 IBDQ 56 ertapenem 56 #OHD 56 Kaplan Meier analysis 56 bridging fibrosis 56 VIIBRYD 56 Hypertrophic cardiomyopathy 56 adjunctive placebo 56 afterload 56 oxycodone CR 56 postoperative delirium 56 discontinuations due 56 primary aldosteronism 56 androgen deprivation 56 systemic corticosteroid 56 meta regression 56 CR nPR 56 NMIBC 56 Neutropenia 56 silent myocardial ischemia 56 IDDM 56 hypoventilation 56 anginal symptoms 56 symptomatic hyponatremia 56 exacerbations 56 annualized relapse 56 rhythm disturbances 56 comorbidity 56 preserved systolic 56 UA NSTEMI 56 clinically meaningful reductions 56 aspartate aminotransferase 56 atrophic gastritis 56 sotalol 56 salivary flow 56 Brief Psychiatric 56 extrapyramidal symptoms EPS 56 tHcy 56 ICD implantation 56 LOVENOX 56 intra abdominal abscess 56 cardiac repolarization 56 proliferative retinopathy 56 urinary cortisol 56 NATRECOR R 56 wound dehiscence 56 cardiovascular cerebrovascular 56 Sleep disturbances 56 PSADT 56 glomerular filtration 56 cystoid macular edema 56 cardiomegaly 56 Lactic acidosis 56 mechanically ventilated patients 56 hyperlipidaemia 56 metastatic GIST 56 Hepatic encephalopathy 56 hematologic adverse 56 perioperative morbidity 56 intravenous diuretics 56 macroalbuminuria 56 cytomegalovirus infection 56 dysglycemia 56 thickness IMT 56 preterm newborns 56 linaclotide treated 56 urolithiasis 56 gastrointestinal perforation 56 Hypoglycemia 56 lymphopenia 56 nicardipine 56 Coronary heart 56 anemia hemoglobin 56 mitral regurgitation MR 56 LV systolic dysfunction 56 prespecified secondary 56 peripheral arterial occlusive disease 56 Bronchopulmonary Dysplasia 56 arrhythmogenic 56 adverse cytogenetics 56 comorbid illnesses 56 mitral insufficiency 56 glomerular filtration rate 56 familial aggregation 56 Peripheral arterial disease 56 PLX STROKE targeting 56 mediastinitis 56 mucosal inflammation 56 PASI scores 56 pancytopenia 56 severe hypoglycemia 56 diastolic BP 56 hepatocellular carcinoma liver 56 adrenal suppression 56 renal impairment 56 Kaplan Meier curve 56 angiographic outcomes 56 nocturnal hypoglycemia 56 QTc 56 cardiogenic pulmonary edema 56 cardiovascular disease hypertension 56 Diabetes mellitus 56 interstitial pneumonia 56 QT prolongation 56 venous thrombosis 56 severe hypersensitivity reactions 56 cerebral ischemia 56 aldosterone antagonist 56 contrast induced nephropathy 56 ECG abnormalities 56 neutropenic fever 56 systolic BP 56 aneurysm rupture 56 mg BID dose 56 PAOD 56 prasugrel uh prevented 56 vein thrombosis 56 glucocorticoid induced 56 HSCT 56 apneic 56 hematologic toxicity 56 status epilepticus 56 Ischemic stroke 56 Postoperative 56 medication nonadherence 56 ICD shocks 56 mHRPC 56 ischemic lesions 56 hypercholesterolaemia 56 aortic regurgitation 56 cerebral infarctions 56 pathologic fracture 56 D dimer 56 plasma triglycerides 56 cardioembolic 56 comorbidities 56 fibrosis scarring 56 euthyroid 56 fulminant hepatic failure 56 affective psychosis 56 Thromboembolic 56 KIF6 carriers 56 congestive cardiac 56 Cypher Stent 56 Scale EDSS score 56 antiarrhythmic drug 56 prospectively stratified 56 serum potassium 56 CC genotype 56 Y BOCS 56 eosinophilia 56 vertebral fracture 56 neurocognitive outcomes 56 Dyspnea 56 obstructive apnea 56 obstructive CAD 56 lower extremity amputations 56 sternal wound infections 56 Tumor shrinkage 56 obstructive coronary 56 cardiovascular thrombotic 56 liver metastasis 56 p = .# [001] 56 recurrent wheezing 56 Chronic Heart Failure 56 cTnI 56 NHANES III 56 hypocalcemia 56 depression suicidal ideation 56 VAD implantation 56 headache nasopharyngitis 56 Renal impairment 56 DVT PE 56 asystole 56 morbidity 56 maternal morbidity 56 atrioventricular valve 56 indicates cardio circulatory 56 Systolic 56 repeat paracentesis 56 pulmonary exacerbation 56 HES CEL 56 albumin excretion rate 56 systolic function 56 endometrial carcinoma 56 impaired glucose metabolism 56 BEXXAR Therapeutic Regimen 56 = #.#-#.# 56 endoscopic remission 56 neointimal hyperplasia 56 NIH CPSI 56 PCWP 56 symptomatic carotid stenosis 56 femoral neck fracture 56 overt nephropathy 56 virologic failure 56 chronic renal insufficiency 56 Hemorrhagic strokes 56 de novo AML 56 dyslipidemia hypertension 56 impaired cognition 56 elevated fasting glucose 56 DAS# CRP 56 coronary stenoses 56 cytogenetic response 56 Myelosuppression 56 SUVmax 56 cholecystitis 56 intracranial stenosis 56 cerebral vascular 56 neutropenic sepsis 56 locoregional 56 CP CPPS 56 cerebral perfusion 56 serum ALT 56 liver transaminases 56 pancreatectomy 56 postsurgical 56 apo B 56 nonobese 56 lichen planus 56 ID TLR 56 cystic fibrosis chronic pancreatitis 56 confirmed CCyR 56 veno occlusive disease 56 serum calcium levels 56 carotid artery intima media 56 psychiatric comorbidity 56 Scale EDSS 56 gastrointestinal bleeds 56 sinus rhythm 56 Comorbidity 56 Folfox 56 prognostic indicators 56 obstructive coronary artery 56 nonsevere 56 Coronary artery calcification 56 skeletal metastases 56 hypoperfusion 56 hepatic dysfunction 56 proximal colon 56 endometrial thickness 56 androgen suppression 55 gastric cardia 55 T2DM 55 paroxysmal AF 55 macrovascular 55 aldosterone antagonists 55 colorectal adenomas 55 creatinine ratio 55 optic neuropathy 55 Digoxin toxicity 55 angiographically 55 sinus tachycardia 55 serum BDNF 55 amenorrhoea 55 nonhereditary 55 statistical significance p 55 perinatal asphyxia 55 ‰ ¥ 55 inflammatory rheumatic 55 thromboembolic disorders 55 nonalcoholic steatohepatitis 55 Complication rates 55 rhinoconjunctivitis 55 tricuspid atresia 55 Ejection Fraction 55 tumor progression TTP 55 cryptogenic 55 bowel perforations 55 smoldering myeloma 55 Eisenmenger syndrome 55 receiving INTRON 55 cervicitis 55 potentially modifiable 55 sociodemographic characteristics 55 cardiovascular calcification 55 arterial thromboembolism 55 clinically evaluable 55 atherothrombotic events 55 GG genotype 55 tryptase 55 chronic pancreatitis CP 55 aneurysmal 55 jugular venous 55 SRBD 55 HbA 1c 55 Acute Coronary Syndromes ACS 55 proliferative diabetic retinopathy 55 Aortic stenosis 55 IOP lowering 55 ADHF 55 QRS duration 55 de aths 55 mortality morbidity 55 recurrent UTI 55 metoprolol tartrate 55 CR CRu 55 thickness CIMT 55 Hemorrhagic stroke 55 baseline serum creatinine 55 myocardial infarctions MI 55 acute myocarditis 55 CRp 55 Ventricular Tachycardia 55 creatine kinase MB 55 shorter telomere length 55 angioplasties stents 55 revascularization procedure 55 hypercoagulable 55 Comorbid 55 Ebstein anomaly 55 prolactin levels 55 congenital abnormalities 55 artery reclogging 55 statistically significant predictor 55 subtrochanteric 55 antiarrhythmic medications 55 mild renal impairment 55 nonfatal myocardial infarctions 55 bacterial prostatitis 55 dysuria 55 albumin excretion 55 stent binary restenosis 55 prespecified 55 univariate analyzes 55 hyperphenylalaninemia HPA due 55 serum IGF 55 neurologic progression 55 paresthesias 55 complement inhibitor eculizumab 55 Secondhand smoke exposure 55 decompensated cirrhosis 55 ischaemia